Filing Details
- Accession Number:
- 0001725160-25-000094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-30 17:07:20
- Reporting Period:
- 2025-04-30
- Filing Date:
- 2025-04-30
- Accepted Time:
- 2025-04-30 17:07:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1725160 | Zentalis Pharmaceuticals Inc. | ZNTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1356256 | Dunseth Scott Myers | C/O Zentalis Pharmaceuticals, Inc. 10275 Science Center Drive, Suite 200 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-30 | 21,000 | $1.40 | 281,192 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
